Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | alphaDC1 |
| Trade Name | |
| Synonyms | alpha-type-1-polarized DC|Alpha-type-1 Polarized Dendritic Cells |
| Drug Descriptions |
alphaDC1 is a polarized DC1 vaccine comprising autologous dendritic cells that is matured by treating with chemokines, potentially resulting in enhanced cytokine production and anti-tumor immune response against tumor cells (PMID: 15342370). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C64846 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| alphaDC1 | alphaDC1 | 0 | 0 |
| alphaDC1 + Celecoxib + Interferon alpha-2b + Rintatolimod | Celecoxib Interferon alpha-2b Rintatolimod alphaDC1 | 0 | 1 |
| alphaDC1 + NK-like CTLs | NK-like CTLs alphaDC1 | 0 | 1 |